About VaxSyna
VaxSyna is a company based in Boston (United States) founded in 2020. VaxSyna offers products and services including Vaccines and Therapeutics Platform. VaxSyna operates in a competitive market with competitors including BeiGene, Biological E, Vir Biotechnology, Vaxcyte and Cidara Therapeutics, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$437.2 K (USD), Grant
Apr 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VaxSyna
VaxSyna offers a comprehensive portfolio of products and services, including Vaccines and Therapeutics Platform.
Develops platforms for rapid creation of vaccines and therapeutics against infectious diseases.
Funding Insights of VaxSyna
Investors in VaxSyna
VaxSyna has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for VaxSyna
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VaxSyna
Investment portfolio details for VaxSyna
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VaxSyna
Detailed financials for VaxSyna
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vaxsyna Comparisons
Peer comparison for VaxSyna
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VaxSyna
VaxSyna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Biological E, Vir Biotechnology, Vaxcyte and Cidara Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
Detailed competitors of VaxSyna
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vaxsyna
Complete news archive for VaxSyna
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VaxSyna
VaxSyna was founded in 2020 and raised its 1st funding round 2 years after it was founded.
VaxSyna is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
VaxSyna was founded in 2020 and is headquartered in Boston, United States. Operations are centered in the biotechnology sector, where plant-based vaccines and antibody therapeutics are developed to address pathogenic diseases and cancer. Focus is placed on innovative production methods derived from plant systems, supporting research and development efforts in immunology and oncology applications.
VaxSyna offers Vaccines and Therapeutics Platform.
VaxSyna has 1 investor. Key investors include HHS.